Enjoy complimentary customisation on priority with our Enterprise License!
The dermal facial fillers market is projected to grow by USD 1.45 billion with a CAGR of 9.14%, during the forecast period 2020 to 2025.
The market research report provides valuable insights into the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by end-user (hospitals and dermatological clinics and beauty centres and medical spas) and geography (North America, Europe, Asia, and ROW).
The dermal facial fillers market report also offers information on several market vendors, including AbbVie Inc., Anika Therapeutics Inc., Galderma SA, Huadong Medicine Co. Ltd., Huons Co. Ltd., Merz Pharma GmbH & Co. KGaA, Suneva Medical Inc., Symatese Group, Teoxane SA, and Westlake Dermatology PA among others.
Anika Therapeutics Inc. - The company offers, ELEVESS Dermal Filler as an injectable dermal filler used to correct facial lines and wrinkles. Under the unified segment, the company offers therapeutics and medical products globally, such as hyaluronic acid (HA) therapeutic products for tissue protection, healing and repair.
Get the Dermal Facial Fillers Market Size Forecast by Downloading the Report Sample
Our research report extensively covers external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the dermal facial fillers market during the forecast period.
Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Key Dermal Facial Fillers Market Driver
Key Dermal Facial Fillers Market Challenge
This dermal facial fillers market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
Our In-house experts produce extensive information on the value chain and parent market of the dermal facial fillers market, which vendors can leverage to gain a competitive advantage during the forecast period. The Value Chain information provides an end-to-end understanding of product insight and profit and also optimization and evaluation of business strategies. The players across the value chain include selective data and analysis from entire research findings as per the scope of the report.
Get a glance at the market share of various regions by Requesting a PDF Sample now!
40% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for dermal facial fillers in North America. Market growth in this region will be faster than the growth of the market in the ROW regions. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
To gain insights on the market contribution of various segments Request a PDF Sample
The dermal facial fillers market share growth by the hospitals and dermatological clinics segment will be significant during the forecast period. This report provides an accurate prediction of the contribution of all the segments to the growth of the dermal facial fillers market size and actionable market insights on the post-COVID-19 impact on each segment.
Dermal Facial Fillers Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.14% |
Market growth 2021-2025 |
$ 1.45 billion |
Market structure |
Fragmented |
YoY growth (%) |
8.90 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 40% |
Key countries |
US, UK, Germany, Canada, and Japan |
Competitive landscape |
Leading companies, Competitive Strategies, Consumer engagement scope |
Key companies profiled |
AbbVie Inc., Anika Therapeutics Inc., Galderma SA, Huadong Medicine Co. Ltd., Huons Co. Ltd., Merz Pharma GmbH & Co. KGaA, Suneva Medical Inc., Symatese Group, Teoxane SA, and Westlake Dermatology PA |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.